PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Charles GinsbergTimothy E CravenMichel B ChoncholAlfred K CheungMark J SarnakWalter T AmbrosiusAnthony A KilleenKalani L RaphaelUdayan Y BhattJing ChenGlenn M ChertowBarry I FreedmanSuzanne OparilVasilios PapademetriouBarry M WallClinton B WrightJoachim H IxMichael G Shlipaknull null

Published in: Clinical journal of the American Society of Nephrology : CJASN (2018)

SPRINT participants with CKD and a high serum PTH received less cardiovascular protection from intensive BP therapy than participants with a lower serum PTH.

Keyphrases

blood pressure
high intensity
chronic kidney disease
resistance training
stem cells
type diabetes
bone marrow
body composition
adipose tissue